These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1317 related items for PubMed ID: 17307972

  • 1. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T.
    Circ Res; 2007 Feb 16; 100(3):342-53. PubMed ID: 17307972
    [Abstract] [Full Text] [Related]

  • 2. Renal microcirculation and calcium channel subtypes.
    Homma K, Hayashi K, Yamaguchi S, Fujishima S, Hori S, Itoh H.
    Curr Hypertens Rev; 2013 Aug 16; 9(3):182-6. PubMed ID: 24479750
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels.
    Hansen PB.
    Acta Physiol (Oxf); 2013 Apr 16; 207(4):690-9. PubMed ID: 23351056
    [Abstract] [Full Text] [Related]

  • 5. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
    Ozawa Y, Hayashi K, Nagahama T, Fujiwara K, Saruta T.
    Hypertension; 2001 Sep 16; 38(3):343-7. PubMed ID: 11566902
    [Abstract] [Full Text] [Related]

  • 6. [Renal protective action of T-, L-, and N-type Ca channel blockers].
    Hayashi K.
    Nihon Rinsho; 2004 Mar 16; 62 Suppl 3():654-61. PubMed ID: 15171451
    [No Abstract] [Full Text] [Related]

  • 7. T-type Ca channel blockade as a determinant of kidney protection.
    Hayashi K, Homma K, Wakino S, Tokuyama H, Sugano N, Saruta T, Itoh H.
    Keio J Med; 2010 Mar 16; 59(3):84-95. PubMed ID: 20881449
    [Abstract] [Full Text] [Related]

  • 8. T-type Ca channel blockers in patients with chronic kidney disease in clinical practice.
    Abe M, Okada K, Soma M.
    Curr Hypertens Rev; 2013 Aug 16; 9(3):202-9. PubMed ID: 24479749
    [Abstract] [Full Text] [Related]

  • 9. Pathophysiological significance of T-type Ca2+ channels: role of T-type Ca2+ channels in renal microcirculation.
    Hayashi K, Wakino S, Homma K, Sugano N, Saruta T.
    J Pharmacol Sci; 2005 Nov 16; 99(3):221-7. PubMed ID: 16293936
    [Abstract] [Full Text] [Related]

  • 10. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O, Inayoshi A, Kitayama T, Yao K, Shirakura S, Sasaki K, Kusaka H, Matsubara M.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):424-34. PubMed ID: 18331727
    [Abstract] [Full Text] [Related]

  • 11. Vascular effects of calcium channel antagonists: new evidence.
    Richard S.
    Drugs; 2005 Apr 28; 65 Suppl 2():1-10. PubMed ID: 16398057
    [Abstract] [Full Text] [Related]

  • 12. Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.
    Baylis C, Qiu C, Engels K.
    Am J Kidney Dis; 2001 Dec 28; 38(6):1292-7. PubMed ID: 11728963
    [Abstract] [Full Text] [Related]

  • 13. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H, Yoshida M, Tojo C, Nakano A, Oshima Y, Kojima Y, Noda K, Wang J, Kobara M, Nakata T.
    Hypertens Res; 2011 Apr 28; 34(4):521-9. PubMed ID: 21270815
    [Abstract] [Full Text] [Related]

  • 14. Nitric oxide synthase inhibition activates L- and T-type Ca2+ channels in afferent and efferent arterioles.
    Feng MG, Navar LG.
    Am J Physiol Renal Physiol; 2006 Apr 28; 290(4):F873-9. PubMed ID: 16263803
    [Abstract] [Full Text] [Related]

  • 15. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
    Honda M, Hayashi K, Matsuda H, Kubota E, Tokuyama H, Okubo K, Ozawa Y, Saruta T.
    Clin Sci (Lond); 2001 Oct 28; 101(4):421-7. PubMed ID: 11566080
    [Abstract] [Full Text] [Related]

  • 16. Investigational calcium channel blockers for the treatment of hypertension.
    Tamargo J, Ruilope LM.
    Expert Opin Investig Drugs; 2016 Nov 28; 25(11):1295-1309. PubMed ID: 27696904
    [Abstract] [Full Text] [Related]

  • 17. T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles.
    Poulsen CB, Al-Mashhadi RH, Cribbs LL, Skøtt O, Hansen PB.
    Kidney Int; 2011 Feb 28; 79(4):443-51. PubMed ID: 21068717
    [Abstract] [Full Text] [Related]

  • 18. The role of L- and T-type calcium channels in local and remote calcium responses in rat mesenteric terminal arterioles.
    Braunstein TH, Inoue R, Cribbs L, Oike M, Ito Y, Holstein-Rathlou NH, Jensen LJ.
    J Vasc Res; 2009 Feb 28; 46(2):138-51. PubMed ID: 18765948
    [Abstract] [Full Text] [Related]

  • 19. Aldosterone and the kidney: rapid regulation of renal microcirculation.
    Arima S.
    Steroids; 2006 Apr 28; 71(4):281-5. PubMed ID: 16289172
    [Abstract] [Full Text] [Related]

  • 20. [Pleiotropic effects of new generation calcium channel blockers on cardiovascular protections].
    Ogimoto A, Higaki J.
    Clin Calcium; 2013 Apr 28; 23(4):569-74. PubMed ID: 23545747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.